Inflammatory cells in renal regeneration

Renal Failure

Volumn 18, Issue 3, 1996, Pages 355-375

  Ghielli, Manuela ^a   Verstrepen, Walter A ^a   Nouwen, Etienne J ^a   De Broe, Marc E ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; MONOCLONAL ANTIBODY; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; ANIMAL CELL; APOPTOSIS; CELL INFILTRATION; CELL PROLIFERATION; CELL REGENERATION; CONFERENCE PAPER; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATORY CELL; KIDNEY CELL; KIDNEY FUNCTION; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE INJURY;

EID: 0029955590     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609052806     Document Type: Conference Paper

References (106)

1. Brezis M, Rosen S, Epstein FH: Acute renal failure. In BM Brenner, F Rector, eds., The Kidney, 4th ed. Philadelphia, WB Saunders, 1991, pp 993-1061.
2. Iaina A, Schwartz D: Renal tubular cellular and molecular events in acute renal failure. Nephron 68:413-416, 1994.
3. Rosen S, Brezis M, Stillman I: The pathology of nephrotoxic injury: a reappraisal. Miner Electrolyte Metab 20:174-180, 1994.
4. Beck F, Thurau K, Gstraunthaler G: Pathophysiology and pathobiochemistry of acute renal failure. In The Kidney: Physiology and Pathophysioiogy, 2nd ed. New York, Raven Press, 1992, Chap 94.
5. Toback FG: Regeneration after acute tubular necrosis. Kidney Int 41:226-246, 1992.
6. Liu S, Humes HD: Cellular and molecular aspects of renal repair in acute renal failure. Curr Opin Nephrol Hypertens 2:618-624, 1993.
7. Fish EM, Molitoris BA: Alterations in epithelial polarity and the pathogenesis of disease states. N Engl J Med 330(22):1580-1588, 1994.
8. Wolf G, Neilson EG: Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 39:401-420, 1991.
9. Sedor JR: Cytokines and growth factors in renal injury. Semin Nephrol 12(5):428-440, 1992.
10. Segal R, Fine LG: Polypeptide growth factors and the kidney. Kidney Int 36(suppl 27):S2-S10, 1989
11. Reiss R, Funke AJ, Cieslinski DA, Humes HD: Transforming growth factor-alpha (TGFα) accelerates renal repair and recovery following ischemic injury to the kidney. Kidney Int 37:492, 1990 (abstract).
12. Daniel T: Peptide growth factors and the kidney. In The Kidney: Physiology and Pathophysiology, 2nd ed. New York, Raven Press, 1992, chap. 93.
13. Kujubu DA, Fine LG: Physiology and cell biology update: polypeptide growth factors and their relation to renal disease. Am J Kidney Dis 14(1):61-73, 1989.
14. Verstrepen WA, Nouwen EJ, De Broe ME: Renal epidermal growth factor and insulin-like growth factor 1 in acute renal failure. Nephrol Dial Transplant, suppl 4:57-68, 1994.
15. Nouwen EJ, De Broe ME: EGF and TGF-α in the human kidney: identification of octopal cells in the collecting duct. Kidney Int 45:1510-1521, 1994.
16. Kanda S, Nomata K, Saha PK, Nishimura N, Yamada J, Kanatake H, Saito Y: Growth factor regulation of the renal cortical tubular cells by epidermal growth factor, insulin-like growth factor-1, acidic and basic fibroblast growth factor, and transforming growth factor-β in serum free culture. Cell Biol Int Rep 13:687-699, 1989.
17. Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84:1757-1761, 1989.
18. Coimbra TM, Cieslinski DA, Humes HD: Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 259:F438-F443, 1990.
19. Morin NJ, Laurent G, Nonclercq D, Toubeau G, Heuson-Stiennon J-A, Bergeron MG, Beauchamp D: Epidermal growth factor accelerates renal tissue repair in a model of gentamicin nephrotoxicity in rats. Am J Physiol 263:F806-F811, 1992.
20. 2-induced acute renal failure: the effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA. J Am Soc Nephrol 5:1782-1791, 1995.
21. Hammerman MR, Miller SB: Therapeutic use of growth factors in renal failure. J Am Soc Nephrol 5:1-11, 1994.
22. Mendley SR, Toback FG: Autocrine and paracrine regulation of kidney epithelial cell growth. Annu Rev Physiol 51:33-50, 1988.
23. Behrens MT, Corbin AL, Hise MK: Epidermal growth factor receptor regulation in rat kidney: two models of renal growth. Am J Physiol 257:F1059-F1064, 1989.
24. Safirstein R, Price PM, Saggi SJ, Harris RC: Changes in gene expression after temporary renal ischemia. Kidney Int 37:515-1521, 1990.
25. Storch S, Saggi S, Megyesi J, Price PM, Safirstein R: Ureteral obstruction decreases renal prepro-epidermal growth factor and Tamm-Horsfall expression. Kidney Int 46:1207-1251, 1994.
26. Verstrepen WA, Nouwen EJ, Xiao S Yue, De Broe ME: Altered growth factor expression during toxic proximal tubular necrosis and regeneration. Kidney Int 43:1267-1279, 1993.
27. Verstrepen WA, Nouwen EJ, Zhu MQ, Ghielli M, De Broe ME: Time course of growth factor expression in mercuric chloride acute renal failure. Nephrol Dial Transplant 10, 1995 (in press).
28. Nouwen EH. Verstrepen WA, De Broe ME: Epidermal growth factor during acute renal failure. Renal Failure 16:49-60, 1994.
29. Leonard I, Zanen J, Nonclercq D, Toubeau G, Heuson-Stiennon J-A, Beckers JF, Falmagne P, Schaudies RP, Laurent G: Modification of immunoreactive EGF and EGF-receptor after acute tubular necrosis induced by tobramycin or cisplatin. Renal Failure 16:583-608, 1994.
30. Deng JT, Verpooten GA, Malesys J, Verstrepen WA, Nouwen EJ, De Broe ME: Decreased renal epidermal growth factor expression in Cs-A treated rats. Transplant Proc 26:2842-2844, 1994.
31. Salido EC, Barajas L, Lechago J, Laborde NP, Fisher DA : Immunocytochemical localization of epidermal growth factor in mouse kidney. J Histochem Cytochem 34:1155-1160, 1986a.
32. Goodyer PR, Kachra Z, Bell C, Rozen R: Renal tubular cells are potential targets for epidermal growth factor. Am J Physiol 255:F1191-F1196, 1988.
33. Neilson EG: Pathogenesis and therapy of interstitial nephritis. Kidney Int 35:1257-1270, 1989.
34. Caldwell MD: Topical wound therapy - an historical perspective. J Trauma 30(suppl 12):S116-S122, 1990.
35. Kunt TK: Basic principles of wound healing. J Trauma 30(suppl 12): S122-S128, 1990.
36. Cromack DT, Porras-Reyes B, Mutoe TA: Current concepts in wound healing: growth factor and macrophage interaction. J Trauma 30(suppl 12):S129-S133, 1990.
37. Knighton DR, Philips GD, Fiegel VD: Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor. J Trauma 30(suppl 12):S134-S144, 1990.
38. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331(19):1286-1292, 1994.
39. Strutz F, Neilson EG: The role of lymphocytes in the progression of interstitial disease. Kidney Int 45(suppl 45):S106-S110, 1994.
40. Kuncio GS, Neilson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550-556, 1991.
41. Schainuck LI, Striker GE, Cutler RE, et al: Structural-functional correlations in renal disease. Part II: the correlations. Human Pathol 1:613, 1970.
42. Halliwell B: Free radicals, antioxidants, and human disease: curiosity, cause or consequence? Lancet 344:721-724, 1994.
43. Glauser MP, Meylan P, Bille J: The inflammatory response and tissue damage. The example of renal scars following acute renal infection. Pediatr Nephrol 1:615-622, 1987.
44. Thornton MA, Winn R, Alpers CE, Zager RA: An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am J Pathol 135(3):509-515, 1989.
45. Bonventre JV: Mechanisms of ischemic acute renal failure. Kidney Int 43:1160-1178, 1993.
46. Klausner JM, Paterson IS, Goldman G, Kobzik L, Rodzen C, Lawrence R, Valeri CR, Shepro D, Hechtman HB: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 256:F794-F802, 1989.
47. Ma X-L, Tsao PS, Lefer AM: Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest 88:1237-1243, 1991.
48. Bienvenu K, Granger DN: Leukocyte adhesion in ischemia/reperfusion. Blood Cells 19:279-289, 1993.
49. Rovin BH, Harris KPG, Morrison A, Klahr S, Schreiner GF: Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab Invest 63(2):213-220, 1990.
50. Cuppage FE, Tate A: Repair of the nephron following injury with mercuric chloride. Am J Pathol 14:58-65, 1967.
51. Klahr S: Interstitial macrophages. Semin Nephrol 13(5):488-495, 1993.
52. Schreiner GF, Harris KPG, Purkerson ML, Klahr S: Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 34:487-493, 1988.
53. Eddy AA, Michael AF: Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int 33:14-23, 1988.
54. Rubin-Kelly VE, Jevnikar AM: Antigen presentation by renal tubular epithelial cells. J Am Soc Nephrol 2:13-26, 1991.
55. Hansson GK, Holm J, Holm S, Foter Z, Hedrich H-J, Fingerle J: T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci USA 88:10530-10534, 1991.
56. Kitamura A, Kitamura M, Nagasawa R, Maruyama N, Mitarai T, Takahashi T, Isoda K: Renal fibroblasts are sensitive to growth-repressing and matrix reducing factors from activated lymphocytes. Clin Exp Immunol 91:516-520, 1993.
57. Vaamonde CA, Pardo V, Fajardo C, Rodriguez R, Oliver R, Garcia M, Cason L: The nude rat is protected against gentamycin nephrotoxicity (abstract). J Am Soc Nephrol 3:713, 1992.
58. Vaamonde CA, Rodriguez I. Rodriguez R, Garcia M, Cason L, Pardo V. Young lewis rats are protected from gentamicin induced nephrotoxicity (G-NTX): role of the cortical interstitial cell infiltrate. Int Soc Nephrol Madrid, July 2-6, 1995, p 156.
59. 2-NTX) (abstract). Int Soc Nephrol Madrid, July 2-6, 1995, p 153.
60. Ali H, Oliver R, Rodriguez G, Cason L, Garcia M, Vaamonde CA: Strain influences the response to nephrotoxic doses of gentamicin in the rat. J Am Soc Nephrol 4(3):748, 1993.
61. Romson LR, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR: Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67(5):1016-1023, 1983.
62. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW: Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 17(5):915-923, 1993.
63. Kelly KJ, Williams WW, Colvin RB, Bonventre JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA91:812-816, 1994.
64. McEver RP: Leukocyte-endothelial cell interactions. Curr Opinion Cell Biol 4:840-849, 1992.
65. Alvarez-Chiva V: Adhesion molecules in Nephrology. Adv Nephrol 23:213-221, 1994.
66. Kyle GM, Luthra R, Bruckner JV, Mackenzie WF, Acosta D: Assessment of functional, morphological, and enzymatic tests for acute nephrotoxicity induced by mercuric chloride. J Toxicol Environ Health 12:99-117, 1983.
67. Guiliano RA: Renal handling of aminoglycosides: cortical uptake and release as an approach to the understanding of nephrotoxicity. PhD thesis, Universitaire Instelling Antwerpen, 1986.
68. Verstrepen WA: Acute renal failure in the rat: temporal and spatial distribution patterns of tubular injury, cell proliferation and infiltration in relation to endogenous growth factor expression. PhD thesis. Universtaire Instelling Antwerpen, 1995.
69. De Broe ME, Paulus GJ, Verpooten GA, Roels F, Buyssens N, Wedden R, Van Hoof F, Tulkens PM: Early effects of gentamicin, tobramicin and amikacin on the human kidney. Kidney Int 25:643-652, 1984.
70. Giuliano RA, Paulus GJ, Verpooten GA, Pattyn VM, Pollet DE, Nouwen EJ, Laurent G, Carlier M-B, Maldague P, Tulkens PM, De Broe ME: Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int 26:838-847, 1984.
71. Harris NR, Benoit JN, Granger DN: Capillary filtration during acute inflammation: role of adherent neutrophils. Am J Physiol: H1623-H1628, 1993.
72. Adams DH, Shaw S: Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet 343:831-836, 1994.
73. Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497, 1975.
74. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldman H: Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548-551, 1984.
75. Roitt I: Essential Immunology, 7th ed. Blackwell Scientific Publications, 1991.
76. Waldmann H: Manipulation of T-cell responses with monoclonal antibodies. Ann Rev Immunol 7:407-444, 1989.
77. Deaton DH, Posselt AM, Naji A, Barker CF: Selective T-cell depletion of recipients in allogeneic small bowel transplantation (SBT) in the rat. Transplant Proc 23(1):283-284, 1991.
78. Hall BM: Therapy with monoclonal antibodies to CD4: potential not appreciated? Am J Kidney Dis 14(5-S2):71-77, 1989.
79. Benjamin RJ, Cobbold SP, Clark MR, Waldman H: Tolerance to rat monoclonal antibodies. Implications for serotherapy. J Exp Med 163:1539-1552, 1986.
80. Jaffers GJ, Fuller TC, Cosimi B, Russell PS, Winn HJ, Colvin RB: Monoclonal antibody therapy. Antiidiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation 41(1):572-578, 1986.
81. Chatenoud L, Bach J-F: Antigenic modulation - a major mechanism of antibody action. Immunol Today 5(1):20-25, 1984.
82. Boltz-Nitulescu G, Bazin H, Spiegelberg HL: Specificity of Fc Receptors for IgG2a, IgGl/IgG2b, and IgE on rat macrophages. J Exp Med 154:374-384, 1981.
83. Kawasaki K, Yaoita E, Yamamoto T, Kihara I: Depletion of CDS positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Int 41:1517-1526.
84. Hougen HP: The athymic nude rat. APMIS 99:suppl 21, 1991.
85. Cash JM, Remmers EF, Goldmuntz EA, Crofford LJ, Zha H, Hansen CT, Wilder RL: Genetic mapping of the athymic nude (rnu) locus in the rat to a region on chromosome 101. Mammalian Genome 4:37-42, 1993.
86. nz) nude rat. Morphological characteristics of the lymphoid system. Ajebak 59(pt 3):277-286, 1981.
87. Lotzová E, Savary CA, Stringfellow DA, Drewniko B, Gray KN, Raulston GL, Jardine JH: Analysis of natural killer cell activity in random-bred rowett athymic rats. Exp Cell Biol 52:53-59, 1984.
88. Svendson UG, Koch C, Weredelin O, Christiansen P: Studies on the thymus-dependent immunity in the rat mutant "nude." Acta Path Microbiol Scand Sect C 89:293-295, 1981.
89. Schwinzer R, Hedrich H-J, Wonigeit K: T cell differentiation in athymic nude rats (rnu/rnu): demonstration of a distorted T cell subset structure by flowcytometry analysis. Eur J Immunol 19:1841-1847, 1989.
90. Rocha B, Vassalli P, Guy-Grand D: Thymic and extrathymic T-cell development. The extrathymic T-cell development pathway. Immunol Today 13(11):449-454, 1992.
91. Bolton EM, Gracie JA, Bradley JA: Phenotype and function of extrathymic cells invading rejecting renal allografts in the nude rat. Transplant Proc 21(1):344-345, 1989.
92. Davila DR, Brief S, Simon J, Hammer RE, Brinster RL, Kelley KW: Role of growth hormone in regulating T-dependent immune events in aged, nude and transgenic rodents. J Neurosci Res 18:108-116, 1987.
93. Rolstad B, Fossum S, Ford WL, Smith M: The rowett nude (rnu) rat as a host in the popliteal lymph node GVH reaction. Adv Exp Med Biol 149:569-576, 1982.
94. Sarawar SR, Yang CP, Bell EB: T-cell receptor-bearing cells from athymic nude rats respond to alloantigen in vitro but are defective in vivo. Immunology 73:334-341, 1991.
95. van Rooijen N: The liposome-mediated macrophage "suicide" technique. J Immunol Methods 124:1-6, 1989.
96. van Rooijen N, Kors N, vd Ende M, Dijkstra CD: Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphate Tissue Res 260:215-222, 1990.
97. Soesatyo M, Biewenga J, van Rooijen N, Kors N, Sminia T: The in situ immune response of the rat after intraperitoneal depletion of macrophages by liposome-encapsulated dichloromethylene diphosphonate. Res Immunol 142:533-540, 1991.
98. Huitinga I, van Rooijen N, de Groot CJA, Uitdehaag BMJ, Dijkstra CD: Suppression of experimental allergic encephalomyelitis in lewis rats after elimination of macrophages. J Exp Med 172:1025-1033, 1990.
99. Bishop GA, Hall BH: Expression of leukocyte and lymphocyte adhesion molecules in the human kidney. Kidney Int 36:1078-1085, 1989.
100. Kubes P, Jutila M, Payne D: Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 95:2510-2519, 1995.
101. Wilson I, Gillinov AM, Curtis WE, DiNatale J, Burch RM, Gardner TJ, Cameron DE: Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart. Circulation 88:372-379, 1993.
102. Eddy AA, McCulloch L, Adams J, Liu T: Interstitial nephritis induced by protein overload proteinuria. Am J Pathol 135:719-733, 1989.
103. Giulliano RA, Paulus GJ, Verpooten GA, Pattyn VM, Pollet DE, Nouwen EJ, Laurent G, Carlier M-B, Maldague P, Tulkens PM, De Broe ME: Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int 26:838-847, 1984.
104. Laurent G, Yernaux V, Nonclerq D, Toubeau G, Maldague P, Tulkens PM, Heuson-Stiennon A: Tissue injury and proliferative response induced in rat kidney by cis-diamminedechloroplatinum (II). Virchows Archiv B Cell Pathol 55:129-145, 1988.
105. Bender WL, Whelton A, Beschorner WE, Darwish MOP, Hall-Craggs M, Solez K: Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs. Immunologic characterization of the inflammatory infiltrate. Am J Med 76:1006-1012, 1984.
106. Boucher A, Droz D, Adafer E, Noël L-H: Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 29:1043-1049, 1986.